Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment

被引:26
|
作者
Pakpour, Sepideh [1 ,2 ,3 ]
Bhanvadia, Amit [4 ,6 ]
Zhu, Roger [5 ,6 ]
Amarnani, Abhimanyu [6 ]
Gibbons, Sean M. [1 ,2 ,3 ]
Gurry, Thomas [1 ,2 ,3 ]
Alm, Eric J. [1 ,2 ,3 ]
Martello, Laura A. [6 ]
机构
[1] Broad Inst, Genome Sequencing & Anal Program, Cambridge, MA 02142 USA
[2] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[3] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[4] Lenox Hill Hosp, Northwell Hlth, Div Digest Dis, New York, NY 10021 USA
[5] NewYork Presbyterian Queens, Surg, Flushing, NY USA
[6] Suny Downstate Med Ctr, Med, Brooklyn, NY 11203 USA
来源
MICROBIOME | 2017年 / 5卷
关键词
COLONIZATION RESISTANCE; DIGESTIVE-TRACT; HEALTH; SURVEILLANCE; MICROBIOME; VANCOMYCIN; DYSBIOSIS; SEQUENCES; BACTERIA; DISEASE;
D O I
10.1186/s40168-017-0368-1
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Colonization by the pathogen Clostridium difficile often occurs in the background of a disrupted microbial community. Identifying specific organisms conferring resistance to invasion by C. difficile is desirable because diagnostic and therapeutic strategies based on the human microbiota have the potential to provide more precision to the management and treatment of Clostridium difficile infection (CDI) and its recurrence. Methods: We conducted a longitudinal study of adult patients diagnosed with their first CDI. We investigated the dynamics of the gut microbiota during antibiotic treatment, and we used microbial or demographic features at the time of diagnosis, or after treatment, to predict CDI recurrence. To check the validity of the predictions, a meta-analysis using a previously published dataset was performed. Results: We observed that patients' microbiota "before" antibiotic treatment was predictive of disease relapse, but surprisingly, post-antibiotic microbial community is indistinguishable between patients that recur or not. At the individual OTU level, we identified Veillonella dispar as a candidate organism for preventing CDI recurrence; however, we did not detect a corresponding signal in the conducted meta-analysis. Conclusion: Although in our patient population, a candidate organism was identified for negatively predicting CDI recurrence, results suggest the need for larger cohort studies that include patients with diverse demographic characteristics to generalize species that robustly confer colonization resistance against C. difficile and accurately predict disease relapse.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment
    Sepideh Pakpour
    Amit Bhanvadia
    Roger Zhu
    Abhimanyu Amarnani
    Sean M. Gibbons
    Thomas Gurry
    Eric J. Alm
    Laura A. Martello
    Microbiome, 5
  • [2] Clostridium difficile infection after antibiotic use
    Brown, Heather L.
    Erickson, Gerald A., Jr.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2020, 33 (07): : 24 - 26
  • [3] Clinical predictors of recurrence after initial treatment of clostridium difficile infection
    Kordian, Tady
    Callard, Michelle
    Teoh, Wun-Chung
    Al-Sohaily, Sam
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 128 - 128
  • [4] Antibiotic Treatment for Clostridium difficile Infection in Adults
    Wilson, Amanda
    AMERICAN JOURNAL OF NURSING, 2018, 118 (07) : 63 - 63
  • [5] A Review of Management of Clostridium difficile Infection: Primary and Recurrence
    Vincent, Yasmeen
    Manji, Arif
    Gregory-Miller, Kathleen
    Lee, Christine
    ANTIBIOTICS-BASEL, 2015, 4 (04): : 411 - 423
  • [6] Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection
    Khanna, S.
    Montassier, E.
    Schmidt, B.
    Patel, R.
    Knights, D.
    Pardi, D. S.
    Kashyap, P. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (07) : 715 - 727
  • [7] Fidaxomicin: A Macrocyclic Antibiotic for the Treatment of Clostridium difficile Infection
    Hardesty, Jennifer S.
    Juang, Paul
    PHARMACOTHERAPY, 2011, 31 (09): : 877 - 886
  • [9] An Analysis of Clostridium difficile Environmental Contamination During and After Treatment for C difficile Infection
    Davies, Kerrie
    Mawer, Damian
    Walker, A. Sarah
    Berry, Claire
    Planche, Timothy
    Stanley, Phil
    Goldenberg, Simon
    Sandoe, Jonathan
    Wilcox, Mark H.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (11):
  • [10] Clinical Features, Diagnosis, and Treatment of Clostridium Difficile Infection After Kidney Transplantation
    Wu, X.
    Cao, G.
    Tian, X.
    Wang, Z.
    Zhang, C.
    Wu, X.
    Yang, Z.
    Ji, B.
    Yan, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1120 - S1120